Acquisitions (Schedule of Intangible Assets Acquired) (Details) (Ofirmev, Specialty Pharmaceuticals, Cadence Pharmaceuticals, Inc., Completed Technology, USD $) In Millions, unless otherwise specified	0 Months Ended
Mar. 19, 2014
Ofirmev \| Specialty Pharmaceuticals \| Cadence Pharmaceuticals, Inc. \| Completed Technology
Intangible Assets Acquired as Part of Business Combination [Line Items]
Completed technology	$ 1,300.0
Intangible assets acquired, amortization period	8 years

The amount of identifiable intangible assets recognized as of the acquisition date.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=25498275&loc=d3e2207-128464

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant